Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

221 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Persistent elevation of serum alanine aminotransferase levels leads to poor survival and hepatocellular carcinoma development in type 1 autoimmune hepatitis.
Miyake Y, Iwasaki Y, Terada R, Okamaoto R, Ikeda H, Makino Y, Kobashi H, Takaguchi K, Sakaguchi K, Shiratori Y. Miyake Y, et al. Among authors: kobashi h. Aliment Pharmacol Ther. 2006 Oct 15;24(8):1197-205. doi: 10.1111/j.1365-2036.2006.03113.x. Aliment Pharmacol Ther. 2006. PMID: 17014578 Free article.
Autoimmune hepatitis with acute presentation in Japan.
Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, Yamamoto K. Miyake Y, et al. Among authors: kobashi h. Dig Liver Dis. 2010 Jan;42(1):51-4. doi: 10.1016/j.dld.2009.04.009. Epub 2009 May 26. Dig Liver Dis. 2010. PMID: 19473895
Evolution of prognostic factors in hepatocellular carcinoma in Japan.
Nouso K, Kobayashi Y, Nakamura S, Kobayashi S, Toshimori J, Kuwaki K, Hagihara H, Onishi H, Miyake Y, Ikeda F, Shiraha H, Takaki A, Iwasaki Y, Kobashi H, Yamamoto K. Nouso K, et al. Among authors: kobashi h. Aliment Pharmacol Ther. 2010 Feb 1;31(3):407-14. doi: 10.1111/j.1365-2036.2009.04179.x. Epub 2009 Oct 22. Aliment Pharmacol Ther. 2010. PMID: 19849688 Free article.
Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy.
Iwasaki Y, Takaguchi K, Ikeda H, Makino Y, Araki Y, Ando M, Kobashi H, Kobatake T, Tanaka R, Tomita M, Senoh T, Kawaguchi M, Shimoe T, Manabe K, Kita K, Shimamura J, Sakaguchi K, Shiratori Y. Iwasaki Y, et al. Among authors: kobashi h. Liver Int. 2004 Dec;24(6):603-10. doi: 10.1111/j.1478-3231.2004.0956.x. Liver Int. 2004. PMID: 15566511
221 results